Zhongzhi Pharmaceutical Holdings Limited provided earnings guidance for the six months ended 30 June 2024. For the six months ended 30 June 2024, a decrease in net profit of around 40% for the six months ended 30 June 2024 are expected as compared to those for the six months ended 30 June 2023. The expected decrease in net profit is mainly attributable to: (i) a decrease in gross profit margin due to structural changes in the products sold; (ii) an increase in investment costs through online channels.